January 2, 2024 · Form 4 insider transaction
Verheyen Patrick bought 24,400 shares of Cue Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy.; This option was granted on January 2, 2024. The shares underlying the option are scheduled to vest in full on the anniversary date of the grant date.